News & Updates
Not only has the pandemic been the dominant issue for the last two years, but the recent floods in the Ahr valley (Rhineland-Palatinate) and neighboring areas have lately added another unexpected and life-threatening situation for many people.
DiaSys is pleased to announce the availability of LDL-c direct FS, a new homogenous assay for direct determination of LDL-cholesterol (LDL-C).
The state Rhineland-Palatinate awards the 2021 Innovation Prize in the category “cooperation“ to DiaSys Diagnostic Systems GmbH along with Hochschule Fresenius – University of Applied Sciences, for developing a new procalcitonin (PCT) test using PETIA technology.
The success story of the owner-managed company DiaSys Diagnostic Systems GmbH started in 1991 by introducing liquid-stable laboratory reagents to determine enzymes and substrates in clinical chemistry.
The amendment of the German Medical Devices Dispensing Ordinance now allows direct selling of COVID-19 antigen rapid tests to all German employers (acc. to Section 2, Par. 3 of the German Occupational Safety and Health Act). In this regard, DiaSys Deutschland Vertriebs-GmbH has issued a press release announcing the sale of rapid diagnostics.
We are pleased to announce a strategic partnership between DiaSys Diagnostic Systems GmbH and ROBERT RIELE GmbH & Co KG, Berlin, for the exclusive marketing of the “505” flow cell photometer.
Like many other exhibitions, this year's AACC Annual Scientific Meeting & Clinical Lab Expo will take place as a virtual event from December 13-17, 2020. DiaSys will participate with a virtual showroom.